4zmg
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Crystal structure of Human Dihydroorotate Dehydrogenase (DHODH) with DH03A338== | |
- | + | <StructureSection load='4zmg' size='340' side='right' caption='[[4zmg]], [[Resolution|resolution]] 1.90Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[4zmg]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ZMG OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ZMG FirstGlance]. <br> | |
- | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=4R5:1-(3,5-DIFLUORO-3-METHOXYBIPHENYL-4-YL)-3-(1,3-THIAZOL-5-YL)UREA'>4R5</scene>, <scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=FMN:FLAVIN+MONONUCLEOTIDE'>FMN</scene>, <scene name='pdbligand=ORO:OROTIC+ACID'>ORO</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | |
- | [[ | + | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Dihydroorotate_dehydrogenase_(quinone) Dihydroorotate dehydrogenase (quinone)], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.3.5.2 1.3.5.2] </span></td></tr> |
- | [[Category: Li, H | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4zmg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4zmg OCA], [http://pdbe.org/4zmg PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4zmg RCSB], [http://www.ebi.ac.uk/pdbsum/4zmg PDBsum]</span></td></tr> |
- | [[Category: | + | </table> |
- | [[Category: | + | == Disease == |
- | [[Category: Zhu, L | + | [[http://www.uniprot.org/uniprot/PYRD_HUMAN PYRD_HUMAN]] Defects in DHODH are the cause of postaxial acrofacial dysostosis (POADS) [MIM:[http://omim.org/entry/263750 263750]]; also known as Miller syndrome. POADS is characterized by severe micrognathia, cleft lip and/or palate, hypoplasia or aplasia of the posterior elements of the limbs, coloboma of the eyelids and supernumerary nipples. POADS is a very rare disorder: only 2 multiplex families, each consisting of 2 affected siblings born to unaffected, nonconsanguineous parents, have been described among a total of around 30 reported cases.<ref>PMID:19915526</ref> |
+ | == Function == | ||
+ | [[http://www.uniprot.org/uniprot/PYRD_HUMAN PYRD_HUMAN]] Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor. | ||
+ | == References == | ||
+ | <references/> | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Li, H L]] | ||
+ | [[Category: Ren, X L]] | ||
+ | [[Category: Zhu, J S]] | ||
+ | [[Category: Zhu, L L]] | ||
+ | [[Category: Fmn binding]] | ||
+ | [[Category: Mitochondria inner membrane]] | ||
+ | [[Category: Oxidoreductase]] | ||
+ | [[Category: Oxidoreductase-oxidoreductase inhibitor complex]] |
Revision as of 19:33, 13 May 2016
Crystal structure of Human Dihydroorotate Dehydrogenase (DHODH) with DH03A338
|